Overview

L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD

Status:
Completed

Trial end date:
2017-10-01

Target enrollment:

Participant gender:

Summary

This study is a 12-week, open-label pilot study to test the effects of MMFS-201-301 on cognition and function in adults with ADHD. Subjects may enter the trial on a stable dose of medication for ADHD, and MMFS-201-301 will be given. Subjects who do not enter on a stable dose of ADHD medication will receive MMFS-201-301 alone.

Phase:

Phase 2

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborators:

Neurocentria, Inc
Neurocentria, Inc.